access to health insurance who decides? · hiv and health insurance •hiv infected persons live...

26
Meeting the Challenges of Change 19 th 21 st Feb, 2012 | Mumbai, India 14 th Global Conference of Actuaries Access to Health Insurance Who Decides? Andres Webersinke ACTUARY (DAV), FASSA, FIAI Gen Re Unit Manager Life/Health R&D Cologne, Germany 1

Upload: others

Post on 17-Jun-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Meeting the Challenges of Change

19th – 21st Feb, 2012 | Mumbai, India

14th Global Conference of Actuaries

Access to Health Insurance –Who Decides?

Andres Webersinke ACTUARY (DAV), FASSA, FIAI

Gen Re Unit Manager Life/Health R&D

Cologne, Germany

1

Page 2: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

UN CRPD (Article 25 (e))

2Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re.

• States shall prohibit discrimination against persons with disabilities in the provision of health insurance, and life insurance …, which shall be provided in a fair and reasonable manner

UN

CR

PD

(Art

icle

25

(e

))

Page 3: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Discussion in India

1. Cover for persons living with HIV

2. Lifelong renewal

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 3

Page 4: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

IRDA’s proposal for PLWHIV

• To have an UW policy on health insurance

• To set clear guidelines

– All possible risks that can be considered

– All those risks which would be denied

– Clearly indicate the specific loadings – subject

to File and Use procedure

• Accepted risks shall not be denied any

claims on grounds of HIV treatment

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 4

Page 5: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

HIV – some background

• Life expectancy is increasing rapidly (UK pop. 1996-06 vs. HIV+ who started treatm. by follow-up period)

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 5

Source: May M. et al. Impact of late diagnosis and treatment on life

expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ 2011;343.

43.546.9

35.6

0

5

10

15

20

25

30

35

40

45

50

Male Female 1996-99 2000-02 2003-05 2006-08

57.861.6

45.8

0

10

20

30

40

50

60

70

Male Female 1996-99 2000-02 2003-05 2006-08

Exact age 35

Exact age 20

Was halved only 15 years ago ...

... now almost 80%

Page 6: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Time of diagnosis is key

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 6

Source: May M. et al. Impact of late diagnosis and treatment on life

expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ 2011;343.

Life expectancy

from age 20-65 of

people who started

antiretroviral

therapy in 2000-8

by CD4 cell count

group at start of

antiretroviral

therapy compared

with that of UK

population)

Page 7: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Higher LE – more insurance

• Example:

– Life plus lump sum disability (ADW definition)

– Subject to adherence monitoring policy

– Significant benefit reduction in case of non-

adherence

– Highly specialised product

• Dealing with sensitive information

• Individualised assessment

• Infrastructure for adherence protocol needed

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 7

Page 8: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Higher LE – more insurance

• Comparison to IRDA’s proposal

– What works for Life, works for Health?

– Can underwriting (risk assessment) of a

medical condition be isolated from other

conditions?

– Benefit reduction in case of non-adherence?

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 8

Page 9: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

HIV and Health insurance

• HIV infected persons live longer but also

for a longer period with sickness

• Prediction of health costs* still uncertain

– €18,000 p.p.p.a (ì 12 lakh)

– €500,000 in total (> ì 3 cr)

• Canadian study shows dependence of

medical expenses according to time of

presentation– Diagnosed with HIV at CD4 counts < 350/mm3 =: late presenter

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 9

* Estimates from German

private health insurers

Page 10: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Mean cumulative PPPA total care cost by year (until patient moved, died or 2009)

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 10

0

1

2

3

4

5

6

7

8

9

10<350

≥350

In ì la

kh

by C

D4 c

ount

gro

up a

t dia

gnosis

Originally in 2009 Can$. Converted with end 2009 exchange rate. DOI: 10.1155/2012/757135

Page 11: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

HIV and Health insurance

• Treating PLWHIV is expensive

• Increased initial costs can be defrayed

over time

• Early detection / access to care are key

• Focus of care is shifting from immuno-

deficiency-related opportunistic infections

or AIDS-defining malignancies to ART-

related toxicities etc. (based on the Swiss HIV Cohort Study)

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 11

Page 12: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

HIV and non-AIDS co-morbidities

• CVD

• Osteoporosis

• DM

• non-AIDS defining malignancies

• Psychiatric diseases

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 12

Page 13: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Current situation

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 13

Typical Exclusion

The Company shall not be liable or make any payment for any claim

directly or indirectly caused by, based on, arising out of or howsoever

attributable to any of the following:

xv. Any sexually transmitted diseases. Acquired Immune Deficiency

Syndrome (AIDS), AIDS related complex syndrome (ARCS) and

all diseases caused by and/or related to the HIV.

Page 14: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Underwriting HIV

1. Diagnosis of HIV infection

2. Additional data on HIV status

– Particular data protection needs

3. Full health questionnaire and medical

report also on all co-morbidities

4. Holistic assessment of the individual’s

risk

5. Assessment almost always requires

opinion of the CMOPresentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 14

Page 15: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Underwriting HIV

• CLEAR uw guidelines for HIV are nice to

have, but the assessment of HIV and co-morbidities is what counts

• Where medical changes are so fast and

yet so uncertain, guidelines may be

unsuitable for a File & Use approach

• Other underwriting guidelines are not

treated in the same way

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 15

Page 16: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Instead...

• ... of forcing the industry to a promise not

possible:

– Education and prevention

• e’ers may be interested in group life cover with an

HIV/AIDS prevention and treatment cover – an

investment to ensure that educated staff remain

employable for as long as possible

• Insurer should be able to adjust benefit levels in

case of non-adherence

– State-sponsored schemes for the masses and

needy

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 16

Page 17: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Competition

• Different marketing

strategies require

different u/w

guidelines

(DM vs. Long Qn)

• Ensures that needs-

based products are

designed and offered

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 17

Page 18: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Discussion in India

1. Cover for persons living with HIV

2. Lifelong renewal

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 18

Page 19: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Refusal to renew health for seniors?

• This insurance is available to a person

between the age of 18 to 59 years. … the

Policy can be renewed up to the age of 80

years

• If the insured has taken continuous

Mediclaim insurance policy with us for at

least 5 years prior to … 80 the policy can

be renewed … to the age of 90 years as a

special case … on case to case basis

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 19

Page 20: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Hospitalisation costs

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 20

Hospitalisation expenses

Days of hospital stay

females males

Male, aged 43, is set as 100.

Source:

German association of private health

insurers 2010/2011

Medical inflation is

not considered!!

Page 21: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Hospitalisation costs

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 21

Hospitalisation expenses

females males

Male, aged 43, is set to 100

India:

Individual, ì 5 lakh, Mumbai,Star Health (Medi Classic)Max Bupa (Heart Beat)

0

300

600

900

1200

1500

15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100

Page 22: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Hospitalisation costs

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 22

Hospitalisation expenses

15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100

Male, aged 43, is set to 100

India:

Individual, ì 5 lakh, Mumbai,Star Health (Medi Classic)Max Bupa (Heart Beat)

Page 23: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Issues

• Medical expenses at high ages are

notoriously underestimated

• “Age attained”-dependent risk premiums

make health insurance unaffordable at

highest ages

• Service tax does not help

• Medical inflation and long duration erodes

sum insured

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 23

Page 24: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Instead ...

• ... of demanding lifelong renewal:

– Introducing incentives/regulations for (tax-

efficient) medical savings accounts

– Or reviewable level premiums

(and setting up an old-age reserve)

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 24

Page 25: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Summary

• Voluntary private insurance and the obligation to accept

risks do not fit well together

• But the opportunity for business demands we do not

single out or unfairly discriminate

• Risk assessment shall be transparent and based on

evidence

• Insurers must be able to price the risk

• Competition and experience will grow appetite for new

risks

• Incentives / regulations outwith IRDA’s realm achieve

more for the good of the society

Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re. 25

Page 26: Access to Health Insurance Who Decides? · HIV and Health insurance •HIV infected persons live longer but also for a longer period with sickness •Prediction of health costs* still

Contact Details / Disclaimer

Andres WebersinkeHead of Life/Health Research & Development

General Reinsurance AG

Theodor-Heuss-Ring 11

50668 Köln (Cologne), Germany

Tel.: +49 (0)221 9738 684

[email protected]

This presentation is protected by copyright. All the information contained in it has been very carefully

researched and compiled to the best of our knowledge. Nevertheless, no responsibility is accepted for

its accuracy, completeness or currency. In particular, this information does not constitute legal advice

and cannot serve as a substitute for such advice. It may not be duplicated or forwarded without the

prior consent of the author or Gen Re.

26Presentation for the 14th GCA, Mumbai, February 2012. (c) Gen Re.